EFFECT OF PCSK9 INHIBITION WITH EVOLOCUMAB ON THE CONCENTRATION AND COMPOSITION OF LDL SUBFRACTIONS IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE
- Scharnagl, H. (Author)
- D Kannenkeril (Author)
- Tatjana Stojakovic (Author)
- Silbernagel, G. (Author)
- A Bosch (Author)
- März, W. (Author)
- R Schmieder (Author)
Activity: Talk, presentation or poster › Poster